Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

neoadjuvant systemic therapy

  • You have access
    Neoadjuvant Versus Adjuvant Systemic Therapy in Breast Cancer: A Matched Case-control Study
    MARA CAROPRESE, MANUEL CONSON, ANGELA BARILLARO, CHIARA FEOLI, LAURA CELLA, CATERINA OLIVIERO, STEFANIA CLEMENTE, ANTONIO FARELLA, CARMINE DE ANGELIS, MARIO GIULIANO, GRAZIA ARPINO, STEFANIA SCALA and ROBERTO PACELLI
    Anticancer Research August 2024, 44 (8) 3501-3506; DOI: https://doi.org/10.21873/anticanres.17170
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire